Artykuły w czasopismach na temat „Antibody avidity”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Antibody avidity”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Arifa, Julian Eva, Budiman Bela, Silvia Tri Widyaningtyas i Jeanne Elvia Christian. "Penggunaan antigen p24, IDR-Gp41 dan ID2-Pol dalam uji aviditas untuk identifikasi kasus baru pada infeksi HIV-1". Jurnal Biotek Medisiana Indonesia 8, nr 1 (18.12.2019): 1–8. http://dx.doi.org/10.22435/jbmi.v8i1.2578.
Pełny tekst źródłaRacine-Brzostek, Sabrina E., Mohsen Karbaschi, Christian Gaebler, P. J. Klasse, Jim Yee, Marina Caskey, He S. Yang i in. "TOP-Plus Is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability". Clinical Chemistry 67, nr 9 (29.04.2021): 1249–58. http://dx.doi.org/10.1093/clinchem/hvab069.
Pełny tekst źródłaPereira Arias-Bouda, Lenka M., Sjoukje Kuijper, Anouk Van Der Werf, Lan N. Nguyen, Henk M. Jansen i Arend H. J. Kolk. "Changes in Avidity and Level of Immunoglobulin G Antibodies to Mycobacterium tuberculosis in Sera of Patients Undergoing Treatment for Pulmonary Tuberculosis". Clinical Diagnostic Laboratory Immunology 10, nr 4 (lipiec 2003): 702–9. http://dx.doi.org/10.1128/cdli.10.4.702-709.2003.
Pełny tekst źródłaIntner, Sara, Michelle Altrich i Niraj Patel. "Comparison of Pneumococcal Avidity and Antibody Concentration in Children with Recurrent Infections: A Retrospective Pilot Study". Journal of Immunological Sciences 4, nr 4 (10.10.2020): 24–30. http://dx.doi.org/10.29245/2578-3009/2020/4.1194.
Pełny tekst źródłaTiburcio, Monique Gomes Salles, Laís Anversa, Kelly Aparecida Kanunfre, Antonio Walter Ferreira, Virmondes Rodrigues Júnior i Luciana de Almeida Silva. "Anti-Leishmania infantum IgG Antibody Avidity in Visceral Leishmaniasis". Clinical and Vaccine Immunology 20, nr 11 (4.09.2013): 1697–702. http://dx.doi.org/10.1128/cvi.00367-13.
Pełny tekst źródłaMarcipar, Iván S., Marikena G. Risso, Ariel M. Silber, Silvia Revelli i Alberto J. Marcipar. "Antibody Maturation in Trypanosoma cruzi-Infected Rats". Clinical Diagnostic Laboratory Immunology 8, nr 4 (1.07.2001): 802–5. http://dx.doi.org/10.1128/cdli.8.4.802-805.2001.
Pełny tekst źródłaAlex, Diviya, Tennison Inba Raj Williams, Jaiprasath Sachithanandham, Swaminathan Prasannakumar, John Paul Demosthenes, Veena Vadhini Ramalingam, Punitha John Victor, Priscilla Rupali, Gnanadurai John Fletcher i Rajesh Kannangai. "Performance of a Modified In-House HIV-1 Avidity Assay among a Cohort of Newly Diagnosed HIV-1 Infected Individuals and the Effect of ART on the Maturation of HIV-1 Specific Antibodies". Current HIV Research 17, nr 2 (2.09.2019): 134–45. http://dx.doi.org/10.2174/1570162x17666190712125606.
Pełny tekst źródłaYoshida, Márcia, Maria Carmen Arroyo Sanchez i Maria Aparecida Shikanai-Yasuda. "Increased Immunoglobulin G Anti-Paracoccidioides brasiliensis Serum Antibody Avidity as a Predictor of Favorable Posttherapeutic Evolution in Paracoccidioidomycosis". Clinical and Vaccine Immunology 16, nr 11 (2.09.2009): 1583–86. http://dx.doi.org/10.1128/cvi.00265-09.
Pełny tekst źródłaChan, K. H., K. Sonnenberg, M. Niedrig, S. Y. Lam, C. M. Pang, K. M. Chan, S. K. Ma, W. H. Seto i J. S. M. Peiris. "Use of Antibody Avidity Assays for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus Infection". Clinical and Vaccine Immunology 14, nr 11 (19.09.2007): 1433–36. http://dx.doi.org/10.1128/cvi.00056-07.
Pełny tekst źródłaGriswold, William R. "A Quantitative Relationship Between Antibody Affinity and Antibody Avidity". Immunological Investigations 16, nr 2 (styczeń 1987): 97–106. http://dx.doi.org/10.3109/08820138709030567.
Pełny tekst źródłaWelten, Suzanne P. M., Anke Redeker, René E. M. Toes i Ramon Arens. "Viral Persistence Induces Antibody Inflation without Altering Antibody Avidity". Journal of Virology 90, nr 9 (17.02.2016): 4402–11. http://dx.doi.org/10.1128/jvi.03177-15.
Pełny tekst źródłaUsinger, William R., i Alexander H. Lucas. "Avidity as a Determinant of the Protective Efficacy of Human Antibodies to Pneumococcal Capsular Polysaccharides". Infection and Immunity 67, nr 5 (1.05.1999): 2366–70. http://dx.doi.org/10.1128/iai.67.5.2366-2370.1999.
Pełny tekst źródłaBenner, Sarah E., Eshan U. Patel, Oliver Laeyendecker, Andrew Pekosz, Kirsten Littlefield, Yolanda Eby, Reinaldo E. Fernandez i in. "SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors". Journal of Infectious Diseases 222, nr 12 (10.09.2020): 1974–84. http://dx.doi.org/10.1093/infdis/jiaa581.
Pełny tekst źródłaLeite, Marcel, Sonia Siciliano, Lucia Silvieri A. Rocha, Teresa R. Justa, Katia Regina César i Celso F. H. Granato. "Correlation between specific IgM levels and percentage IgG-class antibody avidity to Toxoplasma gondii". Revista do Instituto de Medicina Tropical de São Paulo 50, nr 4 (sierpień 2008): 237–42. http://dx.doi.org/10.1590/s0036-46652008000400010.
Pełny tekst źródłaAlexander, Marina R., Rajesh Ringe, Rogier W. Sanders, James E. Voss, John P. Moore i Per Johan Klasse. "What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure?" Journal of Virology 89, nr 11 (25.03.2015): 5981–95. http://dx.doi.org/10.1128/jvi.00320-15.
Pełny tekst źródłaFENOY, S., M. RODERO, E. PONS, C. AGUILA i C. CUÉLLAR. "Follow-up of antibody avidity in BALB/c mice infected withToxocara canis". Parasitology 135, nr 6 (16.04.2008): 725–33. http://dx.doi.org/10.1017/s0031182008004368.
Pełny tekst źródłaVelander, William H., Rapti D. Madurawe, Anuradha Subramanian, Guneet Kumar, Gurudas Sinai-Zingde, Judy S. Riffle i Carolyn L. Orthner. "Polyoxazoline-Peptide adducts that retain antibody avidity". Biotechnology and Bioengineering 39, nr 10 (25.04.1992): 1024–30. http://dx.doi.org/10.1002/bit.260391006.
Pełny tekst źródłaKangro, Hillar O., Shazad Manzoor i David R. Harper. "Antibody avidity following varicella-zoster virus infections". Journal of Medical Virology 33, nr 2 (luty 1991): 100–105. http://dx.doi.org/10.1002/jmv.1890330207.
Pełny tekst źródłaSchoub, Barry D., Nigel K. Blackburn, Sylvia Johnson, Jo M. McAnerney i Bennie Miller. "Low antibody avidity in elderly chickenpox patients". Journal of Medical Virology 37, nr 2 (czerwiec 1992): 113–15. http://dx.doi.org/10.1002/jmv.1890370207.
Pełny tekst źródłaO'DELL, D. S., i J. L. EBERSOLE. "Avidity of antibody responses toActinobacillus actinomycetemcomitansin periodontitis". Clinical & Experimental Immunology 101, nr 2 (sierpień 1995): 295–301. http://dx.doi.org/10.1111/j.1365-2249.1995.tb08354.x.
Pełny tekst źródłaHarris, Shannon L., How Tsao, Lindsey Ashton, David Goldblatt i Philip Fernsten. "Avidity of the Immunoglobulin G Response to a Neisseria meningitidis Group C Polysaccharide Conjugate Vaccine as Measured by Inhibition and Chaotropic Enzyme-Linked Immunosorbent Assays". Clinical and Vaccine Immunology 14, nr 4 (7.02.2007): 397–403. http://dx.doi.org/10.1128/cvi.00241-06.
Pełny tekst źródłaDollard, Sheila C., Stephanie A. S. Staras, Minal M. Amin, D. Scott Schmid i Michael J. Cannon. "National Prevalence Estimates for Cytomegalovirus IgM and IgG Avidity and Association between High IgM Antibody Titer and Low IgG Avidity". Clinical and Vaccine Immunology 18, nr 11 (14.09.2011): 1895–99. http://dx.doi.org/10.1128/cvi.05228-11.
Pełny tekst źródłaHolliman, R. E., R. Raymond, N. Renton i J. D. Johnson. "The diagnosis of toxoplasmosis using IgG avidity". Epidemiology and Infection 112, nr 2 (kwiecień 1994): 399–408. http://dx.doi.org/10.1017/s0950268800057812.
Pełny tekst źródłaMarcolino, P. T., D. A. O. Silva, P. G. Leser, M. E. Camargo i J. R. Mineo. "Molecular Markers in Acute and Chronic Phases of Human Toxoplasmosis: Determination of Immunoglobulin G Avidity by Western Blotting". Clinical Diagnostic Laboratory Immunology 7, nr 3 (1.05.2000): 384–89. http://dx.doi.org/10.1128/cdli.7.3.384-389.2000.
Pełny tekst źródłaRomero-Steiner, Sandra, Patricia F. Holder, Patricia Gomez de Leon, Willie Spear, Thomas W. Hennessy i George M. Carlone. "Avidity Determinations for Haemophilus influenzae Type b Anti-Polyribosylribitol Phosphate Antibodies". Clinical Diagnostic Laboratory Immunology 12, nr 9 (wrzesień 2005): 1029–35. http://dx.doi.org/10.1128/cdli.12.9.1029-1035.2005.
Pełny tekst źródłaRichmond, J. F. L., S. Lu, J. C. Santoro, J. Weng, Shiu-Lok Hu, D. C. Montefiori i H. L. Robinson. "Studies of the Neutralizing Activity and Avidity of Anti-Human Immunodeficiency Virus Type 1 Env Antibody Elicited by DNA Priming and Protein Boosting". Journal of Virology 72, nr 11 (1.11.1998): 9092–100. http://dx.doi.org/10.1128/jvi.72.11.9092-9100.1998.
Pełny tekst źródłaEkström, Nina, Heidi Åhman, Arto Palmu, Sinikka Grönholm, Terhi Kilpi i Helena Käyhty. "Concentration and High Avidity of Pneumococcal Antibodies Persist at Least 4 Years after Immunization with Pneumococcal Conjugate Vaccine in Infancy". Clinical and Vaccine Immunology 20, nr 7 (8.05.2013): 1034–40. http://dx.doi.org/10.1128/cvi.00039-13.
Pełny tekst źródłaAlam, Mohammad Murshid, Mohammad Arifuzzaman, Shaikh Meshbahuddin Ahmad, M. Ismail Hosen, Mohammad Arif Rahman, Rasheduzzaman Rashu, Alaullah Sheikh, Edward T. Ryan, Stephen B. Calderwood i Firdausi Qadri. "Study of Avidity of Antigen-Specific Antibody as a Means of Understanding Development of Long-Term Immunological Memory after Vibrio cholerae O1 Infection". Clinical and Vaccine Immunology 20, nr 1 (31.10.2012): 17–23. http://dx.doi.org/10.1128/cvi.00521-12.
Pełny tekst źródłaZhu, Xuekai, Lei Wang, Rongzhi Liu, Barry Flutter, Shenghua Li, Jie Ding, Hua Tao, Changzhen Liu, Meiyi Sun i Bin Gao. "COMBODY: one‐domain antibody multimer with improved avidity". Immunology & Cell Biology 88, nr 6 (9.03.2010): 667–75. http://dx.doi.org/10.1038/icb.2010.21.
Pełny tekst źródłaPerciani, C. T., P. S. Peixoto, W. O. Dias, F. S. Kubrusly i M. M. Tanizaki. "Improved method to calculate the antibody avidity index". Journal of Clinical Laboratory Analysis 21, nr 3 (2007): 201–6. http://dx.doi.org/10.1002/jcla.20172.
Pełny tekst źródłaRudnick, Stephen I., i Gregory P. Adams. "Affinity and Avidity in Antibody-Based Tumor Targeting". Cancer Biotherapy and Radiopharmaceuticals 24, nr 2 (kwiecień 2009): 155–61. http://dx.doi.org/10.1089/cbr.2009.0627.
Pełny tekst źródłaPullen, G. R., Margaret G. Fitzgerald i C. S. Hosking. "Antibody avidity determination by ELISA using thiocyanate elution". Journal of Immunological Methods 86, nr 1 (styczeń 1986): 83–87. http://dx.doi.org/10.1016/0022-1759(86)90268-1.
Pełny tekst źródłaAlam, Mohammad Murshid, Daniel T. Leung, Marjahan Akhtar, Mohammad Nazim, Sarmin Akter, Taher Uddin, Farhana Khanam i in. "Antibody Avidity in Humoral Immune Responses in Bangladeshi Children and Adults following Administration of an Oral Killed Cholera Vaccine". Clinical and Vaccine Immunology 20, nr 10 (7.08.2013): 1541–48. http://dx.doi.org/10.1128/cvi.00341-13.
Pełny tekst źródłaCuda, Tahleesa J., Yaowu He, Thomas Kryza, Tashbib Khan, Brian W. Tse, Kamil A. Sokolowski, Cheng Liu i in. "Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer". Contrast Media & Molecular Imaging 2021 (13.09.2021): 1–12. http://dx.doi.org/10.1155/2021/3153278.
Pełny tekst źródłaKorhonen, Maria H., John Brunstein, Heikki Haario, Alexei Katnikov, Roberto Rescaldani i Klaus Hedman. "A New Method with General Diagnostic Utility for the Calculation of Immunoglobulin G Avidity". Clinical Diagnostic Laboratory Immunology 6, nr 5 (1.09.1999): 725–28. http://dx.doi.org/10.1128/cdli.6.5.725-728.1999.
Pełny tekst źródłaSteffen, M. J., i J. L. Ebersole. "Effects of aging on antibody avidity to Mycoplasma pulmonis". Mechanisms of Ageing and Development 78, nr 2 (marzec 1995): 123–44. http://dx.doi.org/10.1016/0047-6374(94)01531-p.
Pełny tekst źródłaAltrich, M. L., M. Smith, M. Ling i J. F. Halsey. "Pneumococcal Antibody Avidity Evaluation in Patients with Suspected Immunodeficiency". Journal of Allergy and Clinical Immunology 125, nr 2 (luty 2010): AB8. http://dx.doi.org/10.1016/j.jaci.2009.12.063.
Pełny tekst źródłaYamamoto, S., K. Tagata, Y. Ishikawa, H. Santsuka, M. Yamada, M. Morimatsu i M. Naiki. "Avidity of antibody and agglutinability of antibody-sensitized latex in latex agglutination test". Veterinary Immunology and Immunopathology 36, nr 3 (kwiecień 1993): 257–64. http://dx.doi.org/10.1016/0165-2427(93)90023-w.
Pełny tekst źródłaFuruya, Andrea K. M., Danielle Hunt, Kirsten St George, Alan P. Dupuis, Laura D. Kramer, Pei-Yong Shi i Susan Wong. "Use of the immunoglobulin G avidity assay to differentiate between recent Zika and past dengue virus infections". Clinical Science 133, nr 7 (kwiecień 2019): 859–67. http://dx.doi.org/10.1042/cs20180874.
Pełny tekst źródłaKourtis, Athena P., Jeffrey Wiener, Tiffany S. Chang, Sheila C. Dollard, Minal M. Amin, Sascha Ellington, Dumbani Kayira, Charles van der Horst i Denise J. Jamieson. "Cytomegalovirus IgG Level and Avidity in Breastfeeding Infants of HIV-Infected Mothers in Malawi". Clinical and Vaccine Immunology 22, nr 12 (30.09.2015): 1222–26. http://dx.doi.org/10.1128/cvi.00460-15.
Pełny tekst źródłaWard, K. N., W. Dhaliwal, K. L. Ashworth, E. J. Clutterbuck i C. G. Teo. "Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody". Journal of Medical Virology 43, nr 4 (sierpień 1994): 367–72. http://dx.doi.org/10.1002/jmv.1890430409.
Pełny tekst źródłaRaviprakash, Kanakatte, Kevin R. Porter, Tadeuscz J. Kochel, Daniel Ewing, Monica Simmons, Irving Phillips, Gerald S. Murphy, Walter R. Weiss i Curtis G. Hayes. "Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques". Microbiology 81, nr 7 (1.07.2000): 1659–67. http://dx.doi.org/10.1099/0022-1317-81-7-1659.
Pełny tekst źródłaTo, Kelvin K. W., Anna J. X. Zhang, Ivan F. N. Hung, Ting Xu, Whitney C. T. Ip, Rebecca T. Y. Wong, Joseph C. K. Ng, Jasper F. W. Chan, Kwok-Hung Chan i Kwok-Yung Yuen. "High Titer and Avidity of Nonneutralizing Antibodies against Influenza Vaccine Antigen Are Associated with Severe Influenza". Clinical and Vaccine Immunology 19, nr 7 (9.05.2012): 1012–18. http://dx.doi.org/10.1128/cvi.00081-12.
Pełny tekst źródłaSowers, Sun B., Jennifer S. Rota, Carole J. Hickman, Sara Mercader, Susan Redd, Rebecca J. McNall, Nobia Williams i in. "High Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection Cases". Clinical and Vaccine Immunology 23, nr 8 (22.06.2016): 707–16. http://dx.doi.org/10.1128/cvi.00268-16.
Pełny tekst źródłaGaensbauer, James T., Jeremy T. Rakhola, Carolyne Onyango-Makumbi, Michael Mubiru, Jamie E. Westcott, Nancy F. Krebs, Edwin J. Asturias, Mary Glenn Fowler, Elizabeth McFarland i Edward N. Janoff. "Impaired Haemophilus influenzae Type b Transplacental Antibody Transmission and Declining Antibody Avidity through the First Year of Life Represent Potential Vulnerabilities for HIV-Exposed but -Uninfected Infants". Clinical and Vaccine Immunology 21, nr 12 (8.10.2014): 1661–67. http://dx.doi.org/10.1128/cvi.00356-14.
Pełny tekst źródłaSandberg, E., G. Bergenholtz, H. Kahu i U. I. Dahlgren. "Low HEMA Conjugation Induces High Autoantibody Titer in Mice". Journal of Dental Research 84, nr 6 (czerwiec 2005): 537–41. http://dx.doi.org/10.1177/154405910508400610.
Pełny tekst źródłaFox, Janet L., Stuart L. Hazell, Leslie H. Tobler i Michael P. Busch. "Immunoglobulin G Avidity in Differentiation between Early and Late Antibody Responses to West Nile Virus". Clinical and Vaccine Immunology 13, nr 1 (styczeń 2006): 33–36. http://dx.doi.org/10.1128/cvi.13.1.33-36.2006.
Pełny tekst źródłaAbou Basha, L. M., A. Y. Shehab, M. Abdel Fattah i A. Bassili. "Performance of IgG avidity in an area endemic for schistosomiasis in Egypt". Eastern Mediterranean Health Journal 08, nr 01 (15.03.2002): 172–80. http://dx.doi.org/10.26719/2002.8.1.172.
Pełny tekst źródłaFink, Ashley L., Kyrra Engle, Rebecca L. Ursin, Wan-Yee Tang i Sabra L. Klein. "Biological sex affects vaccine efficacy and protection against influenza in mice". Proceedings of the National Academy of Sciences 115, nr 49 (19.11.2018): 12477–82. http://dx.doi.org/10.1073/pnas.1805268115.
Pełny tekst źródłaSager, Heinz, Marianne Gloor, Camilla Björkman, Sandra Kritzner i Bruno Gottstein. "Assessment of antibody avidity in aborting cattle by a somatic Neospora caninum tachyzoite antigen IgG avidity ELISA". Veterinary Parasitology 112, nr 1-2 (luty 2003): 1–10. http://dx.doi.org/10.1016/s0304-4017(02)00416-8.
Pełny tekst źródła